FindTrial
Sign In

A case series study of bevacizumab-associated fistula formation in cervical cancer patients.

A case series study of bevacizumab-associated fistula formation in cervical cancer patients. - A case series study of bevacizumab-associated fistula formation in cervical cancer patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000040043
Enrollment
6
Registered
2020-04-24
Start date
2020-04-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or recurrent cervical cancer

Interventions

None listed

Sponsors

St. Mary's Hospital and Chugai Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 6 patients who developed fistulas during Avastin Special Drug Use Surveillance (advanced or recurrent cervical cancer) conducted between June 2016 and January 2018.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Characteristics and prior treatments of patients who developed fistulas after administration of bevacizumab.—

Countries

Japan

Contacts

Public ContactCo., Ltd. Chugai Pharmaceutical

Medical Affairs Div. Medical Science Dept.

cma-clinicaltrial@chugai-pharm.co.jp03-3273-0866

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026